Hims & Hers Health, Inc. Financials
Quarterly XBRL submissions from SEC 10-K and 10-Q filings.
Income Statement (Last 8 Quarters)
(3)| Period | Revenue | YoY % | Net Income | YoY % | Operating Income | EPS |
|---|---|---|---|---|---|---|
| Q3 FY202510-Q · 2025-09-30 | $599.0M | — | $15.8M | — | $11.8M | $0.06 |
| Q2 FY202510-Q · 2025-06-30 | $8.0M | — | $42.5M | — | $26.7M | $0.17 |
| Q1 FY202510-Q · 2025-03-31 | $9.6M | — | -$7.7M | — | $57.9M | $0.20 |
Balance Sheet
| Period | Total Assets | Total Liabilities | Cash & Equivalents | Shareholders Equity |
|---|---|---|---|---|
| Q3 FY202510-Q | $2.2B | $1.7B | $345.8M | $581.0M |
| Q2 FY202510-Q | $131.4M | $1.3B | $1.1B | $712.0M |
| Q1 FY202510-Q | $891.7M | $23.1M | $273.7M | $549.3M |
Cash Flow Highlights
| Period | Operating Income | Net Income | Gross Profit | Shares Outstanding |
|---|---|---|---|---|
| Q3 FY202510-Q | $11.8M | $15.8M | $442.1M | 219,121,219 |
| Q2 FY202510-Q | $26.7M | $42.5M | $416.2M | 217,381,434 |
| Q1 FY202510-Q | $57.9M | -$7.7M | $430.7M | 8,377,623 |
Filings
(4)Methodology
Every figure on this page is pulled directly from Hims & Hers Health, Inc.'s own XBRL submissions to the U.S. Securities and Exchange Commission. XBRL is the standardized tagging format the SEC requires for line items in 10-K and 10-Q filings, which means revenue, net income, and balance-sheet entries are reported by the company itself — not estimated by us.
Cayman Journal reconciles preferred GAAP tags (for example, Revenues, RevenueFromContractWithCustomerExcludingAssessedTax) and normalizes them so quarter-over-quarter comparability is preserved. Our automated ingestion runs nightly; markets editors spot-check flagged anomalies before they appear on the public hub. Where a tag is missing for a given period, we surface an em dash rather than impute a value.
Source documents are linked under Filings above and point to the original EDGAR submission index. Errors should be reported to [email protected].